Significant Ownership of JOHNSON & JOHNSON
- Signature - Title
- /s/ Marc Larkins - Marc Larkins/Secretary
- Location
- New Brunswick, NJ
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by JOHNSON & JOHNSON.
Follow Filing Activity
Follow JOHNSON & JOHNSON and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of JOHNSON & JOHNSON
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVRX | CVRx, Inc. | Common Stock, $0.01 par value | 15% | $28,578,928 | 4,024,861 | JOHNSON & JOHNSON | 31 Dec 2025 | ||
| RAPP | Rapport Therapeutics, Inc. | Common Stock, $0.001 par value | 4.9% | $53,000,690 | 1,784,517 | JOHNSON & JOHNSON | 30 Sep 2025 | ||
| RLYB | Rallybio Corporation | Common Stock, $0.0001 par value | 2.9% | $88,683 | 152,901 | Johnson & Johnson | 31 Mar 2026 |
Schedules 13D/G Reported by JOHNSON & JOHNSON:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.